GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Innospec Inc (NAS:IOSP) » Definitions » Total Current Liabilities

Innospec (Innospec) Total Current Liabilities : $372 Mil (As of Dec. 2023)


View and export this data going back to 1998. Start your Free Trial

What is Innospec Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Innospec's total current liabilities for the quarter that ended in Dec. 2023 was $372


Innospec Total Current Liabilities Historical Data

The historical data trend for Innospec's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innospec Total Current Liabilities Chart

Innospec Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 303.50 252.40 336.60 405.80 371.50

Innospec Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 405.80 381.60 364.90 344.20 371.50

Innospec Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Innospec's Total Current Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=352.1+13.6
+Other Current Liabilities+Current Deferred Liabilities
=5.8+0
=372

Innospec's Total Current Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=352.1+13.6
+Other Current Liabilities+Current Deferred Liabilities
=5.8+0
=372

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Innospec Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Innospec's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Innospec (Innospec) Business Description

Traded in Other Exchanges
Address
8310 South Valley Highway, Suite 350, Englewood, CO, USA, 80112
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The fuel specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field services providers in the extraction of oil and gas. The performance chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.
Executives
Larry Padfield director 8310 S. VALLEY HWY, SUITE 350, DENVER CO 80112
Claudia Poccia director 8310 SOUTH VALLEY HIGHWAY, SUITE 350, ENGLEWOOD CO 80112
Leslie J Parrette director
Barnes Corbin officer: SVP, Corporate Dev and IR 8310 SOUTH VALLEY HIGHWAY, SUITE 350, ENGLEWOOD CO 80112
Philip John Boon other: Marketing Director Pet Specs 8310 S. VALLEY HWY, SUITE 350, DENVER CO 80112
Ian Cleminson officer: Exec VP & CFO OAK DALE, 84 ALBERT ROAD, GRAPPENHALL, WARRINGTON X0 WA4 2PG
Patrick Williams officer: Exec VP & President, Pet Specs 8310 S. VALLEY HWY, SUITE 350, DENVER CO 80112
Bentley Jones David officer: VP, GC & CCO 8310 S. VALLEY HWY, SUITE 350, DENVER CO 80112
David Landless director 8310 S. VALLEY HWY, SUITE 350, DENVER CO 80112
Milton C Blackmore director 8310 S. VALLEY HWY, SUITE 350, DENVER CO 80112
Brian Watt other: VP, Strategic Planning THE LODGE, HUSTHWAITE, YORK X0 YO61 4PD
Catherine Hessner officer: Senior VP - Human Resources 33 STRAWBERRY LANE, WILMSLOW CHESHIRE X0 SK96AQ
Griffin Hardy Louis Iii officer: SVP, HUMAN RESOURCES 8310 SOUTH VALLEY HIGHWAY, SUITE 350, ENGLEWOOD CO 80112
Elizabeth K Arnold director 8310 S. VALLEY HWY, SUITE 350, DENVER CO 80112
Graeme Blair officer: Head of Group Finance 8310 SOUTH VALLEY HIGHWAY, SUITE 350, ENGLEWOOD CO 80112